Sleep apnea-hypopnea syndrome in the elderly;El síndrome de apneas-hipopneas durante el sueño en edades avanzadas

Archivos de Bronconeumologia

Volumn 46, Issue 9, 2010, Pages 479-488

  Martínez García, Miguel Ángel ^a,b   Durán Cantolla, Joaquín ^b,c   Montserrat, José María ^b,d  

^a HOSPITAL GENERAL DE REQUENA   (Spain)

^b HOSPITAL TXAGORRITXU   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Advanced age; Continuous positive airway pressure; CPAP; Diagnosis; Elderly; Epidemology; Impact; SAHS; Sleep apnea hypopnea syndrome; Treatment

Indexed keywords

AGE DISTRIBUTION; CARDIOVASCULAR RISK; ELDERLY CARE; HUMAN; NEUROLOGIC DISEASE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PREVALENCE; SHORT SURVEY; SLEEP APNEA SYNDROME; TREATMENT RESPONSE;

EID: 77956263858     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S1579-2129(10)70116-6     Document Type: Review

References (143)

1. Christensen K., Doblhammer G., Rau R., Vaupel J.W. Ageing populations: the challenges ahead. Lancet 2009, 374:1196-1208.
2. Instituto Nacional de Estadística (INE) 2008. Disponible en: Última visita. Diciembre 2009. http://www.ine.es.
3. Schubert C.R., Karen M.S., Cruickshanks K.J., Dalton D.S., Klein B.E.K., Klein R., et al. Prevalence of sleep problems and quality of life in an older population. Sleep 2002, 25:48-52.
4. Redline S., Kirchner H.L., Quan S.F. The effect of age, sex, etnicity, and sleep-disordered breathing on sleep architecture. Arch Intern Med 2004, 164:406-418.
5. Vgontzas A.N., Bixler E.O., Wittman T. Middle aged men show higher sensitivity of sleep to the arousing effects of corticotropin-releasing hormone than young men: clinical implications. J Clin Endocrinol Metab 2001, 86:1489-1495.
6. Prinz P.N., Moe K.E., Dulberg E.M. Higher plasma IGF-1 levels are associated with increased delta sleep in healthy older men. J Gerontol A Biol Sci Med Sci 1995, 50A:222-226.
7. Van Cauter E., Leproult R., Plat L. Age-related changed in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA 2000, 284:861-868.
8. Mignot E., Lammers G.J., Ripley B. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002, 59:1553-1562.
9. Vgontzas A.N., Zoumakis M., Bixler E.O. Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels. Physiologic and therapeutics implications. J Clin Endocrinol Metab 2003, 88:2087-2095.
10. Shiromani P.J., Lu J., Wagner D. Compensatory sleep response to 12h wakefulness in young and old rats. Am J Physiol Regul Integr Comp Physiol 2000, 278:125-133.
11. Basheer R., Shiromani P.J. Effets of prolonged wakefulness on c-fos and AP1 activity in young and old rats. Brain Res Mol Brain Res 2001, 89:153-157.
12. Kendall A.R., Lewy A.J., Sack R.L. Effects of aging on the intrinsic circadian period of totally blind humans. J Biol Rhythms 2001, 16:87-95.
13. Duffy J.F., Zeitzner J.M., Rimmer D.W. Peak of circadian melatonin rhythm occurs later within the sleep of older subjects. Am J Physiol Endocrinol Metab 2002, 282:e297-e303.
14. Collop N.A. The significance of sleep-disordered breathing and obstructive sleep apnea in the elderly. Chest 1997, 112:867-868.
15. Martínez-García M.A., Soler-Cataluña J.J., Román-Sánchez P., González V., Amorós C., Montserrat J.M. Obstructive sleep apnea has little impact on quality of life in the elderly. Sleep Med 2009, 10:104-111.
16. Launois S.H., Pépin J.L., Lévy P. Sleep apnea in the elderly: A specific entity?. Sleep Med Rev 2007, 11:87-97.
17. Bloom H.G., Ahmed I., Alessi C.A., Ancoli-Israel S., Buysse D.J., Kryger M.H., et al. Evidence-based recommendations for the assessment and management of sleep disorders in older persons. J Am Geriatr Soc 2009, 57:761-789.
18. White D.P., Lombard R.M., Cadieux R.J., Zwillich C.W. Pharyngeal resistance in normal humans: influence of gender, age, and obesity. J Appl Physiol 1985, 58:365-371.
19. Eikermann M., Jordan A.S., Chamberlin N.L., Gautam S., Wellman A., Lo Y.L. The influence of aging on pharingeal collapsibility during sleep. Chest 2007, 131:1702-1709.
20. Harrington J.J., Lee-Chong T. Sleep and older adults. Clin Chest Med 2007, 28:673-684.
21. Bliwise D.L. Normal aging. Principles and Practice of Sleep Medicine 2000, 26-42. Saunders, Philadelphia. 3rd ed. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
22. Young T., Shahar E., Nieto F.J., Redline S., Newman A.B., Gottlieb D.J., et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002, 162:893-900.
23. Duran J, Esnaola S, Rubio R, De La Torre G, Solles J, Goicolea A, et al. Prevalence of obstructive sleep apnoea-hypopnoea and related clinical features in the elderly. A population based-study in the general population aged 71-100. WFSRS. World Conference Sleep odyssey 2001. Punta del Este. Uruguay.
24. Hoch C.C., Reynolds C.F., Monk T.H., Buysse D.J., Yeager A.L., Houck P.r., et al. Comparison of sleep-disordered breathing among healthy elderly in the seventh, eight, and ninth decades of life. Sleep 1990, 13:501-511.
25. Bixler E.O., Vgontzas A.N., Have T.T., Tyson K., Kales A. Effects of age on sleep apnea in men. Prevalencia and severity. Am Respir J Crit Care Med 1998, 157:144-148.
26. Ancoli-Israel S., Kripke D.F., Klauber M.R., Mason W.J., Fel R., Kaplan O. Sleep-disordered breathing in community-dwelling elderly. Sleep 1991, 14:486-495.
27. Zamarrón C., Gude F., Otero Y., Álvarez J.M., Golpe A., Rodríguez J.R. Prevalence of sleep disordered breathing and sleep apnea in 50 to 70 year old individuals. A survey. Respiration 1999, 66:317-322.
28. Campos-Rodríguez F., Fernández Palacín A., Reyes Núñez N., Reina González A. Características clínicas y polisomnográficas del síndrome de apneas durante el sueño localizado en la fase REM. Arch Bronconeumol 2009, 45:330-334.
29. Levy P., Pepin J.L., Malauzat D., Emeriau J.P., Legar J.M. Is sleep apnea syndrome in the elderly a specific entity?. Sleep 1996, 19(3 suppl):s29-s38.
30. Martínez-García MA, Amilibia J, Chiner E, Queipo C, Díaz de Atauri J, Carmona-Bernal C, et al. Apnea del sueño en individuos de edad avanzada. Actividad asistencial (2002-2008) en España. Arch Bronconeumol. 2010. http://dx.doi.org/10.1016/j.arbres.2010.06.007.
31. Bixler E.O., Vgontzas A.N., Lin H.M., Calhoun S.L., Vela-Bueno A., Kales A. Excessive daytime sleepiness in a general population simple: the role of sleep apnea, age, obesity, diabetes, and depresión. J Clin Endocrinol Metab 2005, 90:4510-4515.
32. Whitney C.W., Enroght P.L., Newman B., Bonekat W., Foley D., Quan S.F. Correlates of daytime sleepiness in 4578 elderly persons: the Cardiovascular Health Study. Sleep 1998, 21:27-36.
33. Collop N.A. The significance of sleep-disordered breathing and obstructive sleep apnea in the elderly. Chest 1997, 112:867-868.
34. Roure N., Mediano O., Durán-Cantolla J., García Río F., de la Peña M., Capote F., et al. Influencia del sexo en las variables clínicas y polisomnográficas del síndrome de apnea del sueño. Arch Bronconeumol 2008, 44:685-688.
35. Chiner E., Arriero J., Signes-Costa J., Marco J., Fuentes I. Validación de la versión española del test de somnolencia Epworth en pacientes con síndrome de apnea de sueño. Arch Bronconeumol 1999, 35:422-427.
36. Hernández C. Síndrome de apneas-hipopneas durante el sueño sin somnolencia. Arch Bronconeumol 2009, 45:240-244.
37. Enright P.L., Newman A.B., Wahl P.W., Manolio T.A., Haponik E.F., Boyle P.J. Prevalence and correlates of snoring and observed apneas in 5201 older adults. Sleep 1996, 19:531-538.
38. Saunamaki T., Jehkonen M. Depression and anxiety in obstructive sleep apnea syndrome: a review. Acta Neurol Scand 2007, 116:277-288.
39. Annette M., Chihorek, Abou-Khalil B., Malow B.A. Obstructve sleep apnea is associated with seizure occurrence in older adults with epilepsy. Neurology 2007, 69:1823-1827.
40. Abdal H., Pizzimenti J.J., Purvis C.C. The eye in sleep apnea síndrome. Sleep Med 2006, 7:107-115.
41. Endershaw Y.W., Jonson T.M., Kutner M.H., Ouslander J.G., Bliwise D.L. Sleep-disordered breathing and nocturna in older adulys. J Am Geriatr Soc 2004, 52:957-960.
42. Brassington G.S., King A.C., Bliwise D.L. Sleep problems as a risk factor for falls in a sample of community-dwelling adulys aged 64-99 years. J Am Geriatr Soc 2000, 48:1234-1240.
43. Kadotani H., Kadotani T., Young T., Peppard P.E., Finn L., Colrain I.M., et al. Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA 2001, 285:2888-2890.
44. Gottlieb D.J., DeStefano A.L., Foley D.J., Mignot E., Redline S., Givelber R.J., et al. APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: The Sleep Heart Health Study. Neurology 2004, 63:664-668.
45. Martínez-García M.A., Soler-Cataluña J.J., Ejarque-Martínez L., Soriano Y., Román-Sánchez P., Illa F.B., et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med 2009, 180:36-41.
46. Martínez-García M.A., Galiano-Blancart R., Román-Sánchez P., Soler-Cataluña J.J., Cabero-Salt L., Salcedo-Maiques E. Continuous positive airway pressure in sleep apnea prevents new vascular events after ischemic stroke. Chest 2005, 128:2123-2129.
47. Parra O., Arboix A., Bechich S., Garcia-Eroles L., Montserrat J.M., López J.A., et al. Time course of sleep related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000, 161:375-380.
48. Muñoz R., Durán-Cantolla J., Martínez-Vila E., Gallego J., Rubio R., Aizpuru F., et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke 2006, 37:2317-2321.
49. Consenso Nacional sobre el Síndrome de apneas-hipopneas durante el sueño. Arch Bronconeumol 2005, 41(supl 4):1-110.
50. Cusida C.A., Littner M.R., Morgenthaler T., Alessi C.A., Bailey D., Colemen J., et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005, 28:499-521.
51. Hernández C., Durán-Cantolla J., Lloberes P., González M. Novedades en la epidemiología, la historia natural, el diagnostico y el tratamiento del síndrome de apneas-hipopneas durante el sueno. Arch Bronconeumol 2009, 45(Supl 1):3-10.
52. Camarasa A., Gonzalez Vergara D., Serrano Rebollo J.C., Barbe F. El síndrome de apnea-hipopnea del sueño en 2009. Arch Bronconeumol 2009, 45(Supl.3):14-21.
53. Misra S., Malow B.A. Evaluation of sleep disturbances in older adults. Clin Geriatr Med 2008, 24:15-26.
54. Norman D., Loredo J.S. Obstructive sleep apnea in older adults. Clin Geriatr Med 2008, 24:151-165.
55. Mosko S.S., Dickel M.J., Paul T., LaTour T., Dhillon S., Granim A., et al. Sleep apnea and sleep-related periodic leg movements in community resident seniors. J Am Geriatr Soc 1988, 36:502-508.
56. Mosko S.S., Dickel M.J., Ashurst J. Night-to-night variability in sleep apnea and sleep-related periodic leg movements in the elderly. Sleep 1998, 11:340-348.
57. Stepnowsky C., Johnson S., Dimsdale J., Ancoli-Israel S. Sleep apnea and health-related quality of life in African-American elderly. Ann Behav Med 2000, 22:116-120.
58. Baldwin C.M., Griffith K.A., Nieto J., O'Connor G.T., Walsleben J.A., Redline S. The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep 2001, 24:96-105.
59. Kezirian E.J., Harrison S.L., Ancoli-Israel S., Redline S., Ensrud K., Goldberg A.N., et al. Behavioral correlates of sleep-disordered breathing in older men. Sleep 2009, 32:253-261.
60. Chung S., Yoon I.Y., Shin Y.K., Lee C.H., Kim J.W., Ahn H.J. Endotelial dysfunction and inflammatory reactions of elderly and middle-aged men with obstructive sleep apnea síndrome. Sleep Breath 2009, 13:11-17.
61. Wilson P.W., Pencina M., Jacques P., Selhub J., D'Agostino R., O'Donnell C.J. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes 2008, 1:92-97.
62. Roche F., Gaspoz J.M., Pichot V., Picard-Kossovsky M., Maudoux D., Garcin A., et al. Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly. Eur Respir J 2009, 33:797-803.
63. Nieto F.J., Herrington D.M., Redline S., Benjamin E.J., Robbins J.A. Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 2004, 169:354-360.
64. Lavie P., Lavie L., Herer P. All cause mortality in men with sleep apnea syndrome: declining mortality rates with age. Eur Respir J 2005, 27:1-7.
65. Lavie L., Lavie P. Ischemic preconditioning as a possible explanation for the age decline relative mortality in sleep apnea. Med Hypotheses 2006, 66:1069-1073.
66. Bianchi G., Di Giulio C., Rapino C., Rapino M., Antonucci A., Cataldi A. P53 and p66 proteins compete for hipoxia-inducible factor 1 alpha stabilization in young and old rat hearts exposed to intermittent hypoxia. Gerontology 2006, 52:17-23.
67. Mehra R., Stone K.L., Varosy P.D., Hoffman A.R., Marcus G.M., Blackwell T., et al. Nocturnal arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study. Arch Intern Med 2009, 169:1147-1155.
68. Johansson P., Alehagen U., Svanborg E., Dahlström U., Broström A. Sleep disordered breathing in an elderly community-living population: Relationship to cardiac function, insomnia symptoms and daytime sleepiness. Sleep Med 2009, 10:1005-1011.
69. Endeshaw Y.W., White W.B., Kutner M., Ouslander J.G., Bliwise D.L. Sleep-disordered breathing and 24-hour blood pressure pattern among older adults. J Gerontol A Biol Sci Med Sci 2009, 64:280-285.
70. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
71. Butchner N.J., Sanner B.M., Borgel J., Rup L.C. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med 2007, 176:1274-1280.
72. Nieto F.J., Young T.B., Lind B.K., Shahar E., Famet J.M., Redline S., et al. Assocition of sleep-disordered breathing, sleep apnea, and hipertensión in a large community-based study. Sleep Heart Health Study. JAMA 2000, 283:1829-1836.
73. Lavie P. Mortality in sleep apnoea syndrome: a review of the evidence. Eur Respir Rev 2007, 16:203-210.
74. Yaggi H.K., Concato J., Kernan W.N., Lichtman J.H., Brass L.M., Monhesin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005, 353:2034-2041.
75. Parra O., Arboix A., Bechich S., Garcia-Eroles L., Montserrat J.M., López J.A., et al. Time course of sleep related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000, 161:375-380.
76. Bassetti C.L., Milanova M., Gugger M. Sleep-disordered breathing and acute stroke: diagnosis, risk factors, treatment, evolution and long-term clinical outcome. Stroke 2006, 37:967-972.
77. Phillips B.A., Berry D.T., Lipke-Molby T.C. Sleep-disordered breathing in healthy, aged persons. Fifth and final year follow-up. Chest 1996, 110:654-658.
78. Enright P.L., Newman A.B., Wahl P.W., Manolio T.A., Haponik E.F., Oyle P.J. Prevalence and correlates of snoring and observed apneas in 5201 older adults. Sleep 1996, 19:531-538.
79. Haas D.C., Foster G.L., Nieto F.J., Redline S., Resnick H.E., Robbins J.A., et al. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 2005, 111:614-621.
80. Marshall N.S., Wong K.K.H., Lui P.Y., Cullen S.R.J., Knuiman M.W., Grustein R.R. Sleep apnea as an independent risk factor for all-cause mortality: The Busselton Health Study. Sleep 2008, 31:1079-1085.
81. Young T., Finn L., Peppard P.E., Szklo-Coxe M., Austin D., Nieto J., et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisonsin Sleep Cohort. Sleep 2008, 31:1071-1078.
82. He J., Kryger M.H., Zorich F.J., Conway W., Roth T. Mortality and apnea index in obstructive sleep apnea: experience in 385 male patients. Chest 1988, 94:9-14.
83. Martí S., Sampol G., Muñoz X., Torres F., Roca A., Lloberes P., et al. Mortality in severe sleep apnoea/hipopnoea syndrome patients: impact of treatment. Eur Respir J 2002, 20:1511-1518.
84. Campos-Rodriguez F., Peña-Griñan N., Reyes-Nuñez N., De La Cruz-Morón I., Pérez-Ronchel J., De La Vega-Gallardo F., et al. Mortality in obstructive sleep apnea-hypopnea syndrome treated with positive airway pressure. Chest 2005, 128:624-633.
85. Ancoli-Israel S., Kripke D.F., Klauber M.R., Fell R., Stepnowsky C., Estline E., et al. Morbidity, mortality and sleep disordered breathing in community dwelling elderly. Sleep 1996, 19:277-282.
86. Parra O., Arboix A., Montserrat J.M., Quintó L., Bechich S., García-Eroles L. Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur Respir J 2004, 24:267-272.
87. Ferini-Strambi L., Baietto C., Di Gioia M.R. Cognitive dysfunction in patients with obstructive sleep apnea: partial reversibility after continuous positive airway pressure. Brain Res Bull 2003, 61:87-92.
88. Sforza E., Haba-Rubio J., De Bilbao F., Rochat T., Ibanez V. Performance vigilance task and sleepiness in patients with sleep-disordered breathing. Eur Respir J 2004, 24:279-285.
89. Phillips B.A., Berry D.T., Schmitt F.A., Magan L.K., Gerhardstein D.C., Cook Y.R. Sleep-disordered breathing in the healthy elderly. Chest 1992, 101:345-349.
90. Phillips B.A., Berry D.T., Schmitt F.A., Harbison L., Lipke-Molby T. Sleep-disordered breathing in healthy aged persons: two- and three-year follow-up. Sleep 1994, 17:411-415.
91. Cohen-Zion M., Stepnowsky C., Johnson S., Marler M., Dimsdale J.E., Ancoli-Israel S. Cognitive changes and sleep disordered breathing in eldery: differences in race. J Psychosom Res 2004, 56:549-553.
92. Ancoli-Israel S., Klauber M.R., Butters N., Parker L., Kripke D.F. Dementia in institutionalized elderly: relation to sleep apnea. J Am Geriatr Soc 1991, 39:258-263.
93. Ancoli-Israel S., Coy T. Are breathing disturbances in elderly equivalent to sleep apnea syndrome?. Sleep 1994, 17:77-83.
94. Gehrman P.R., Martin J.L., Shochat T., Nolan S., Corey-Bloom J., Ancoli-Israel S. Sleep-disordered breathing and agitation in institutionalized adults with Alzheimer disease. Am J Geriatr Psychiatry 2003, 11:426-433.
95. Spira A.P., Blackwell T., Stone K.L., Redline S., Cauley J.A., Ancoli-Israel S., et al. Sleep-disordered breathing and cognition in older women. J Am Geriatr Soc 2008, 56:45-50.
96. Hoch C.C., Reynolds III C.F., Nebes R.D., Kupfer D.J., Berman S.R., Campbell D. Clinical significance of sleep-disordered breathing in Alzheimer's disease. J Am Geriatr Soc 1989, 37:138-144.
97. Erkinjuntti T., Partinen M., Sulkava R., Telakivi T., Salmi T., Tilvis R. Sleep apnea in multiinfart dementia and Alzheimer's disease. Sleep 1987, 10:419-425.
98. O'Hara R., Schröder C.M., Kraemer H.C. Nocturnal sleep apnea-hypopnea is associated with lower memory performance in APOE epsolin4 carriers. Neurology 2005, 65:642-644.
99. Harris M., Glozier N., Ratnavadivel R., Grunstein R.R. Obstructive sleep apnea and depression. Sleep Med Rev 2009, 13:437-444.
100. Hoch C.C., Reynolds C.F., Kupfer D.J., Houck P.R., berman S.R., Stack J.A. Sleep-disordered breathing in normal and pathologic aging. J Clin Psychiatry 1986, 47:499-503.
101. Tarasiuk A., greenberg-Dotan S., Simon-Tuval T., Oksenberg A., Reuveni H. The effect of obstructive sleep apnea on morbidity and health care utilization of middle-aged and older adults. JAGS 2008, 56:247-254.
102. Weaver T.E., Chasens E.R. Continuous positive airway pressure treatment for sleep apnea in older adults. Sleep Med Rev 2007, 11:99-111.
103. Barnes M., Houston D., Worsnop C.J., Neill A.M., Mykytyn I.J., Kay A., et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 2002, 165:773-780.
104. Barnes M., McEvoy R.D., Banks S., Tarquinio N., Murray C.G., Vowles N., et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004, 170:656-664.
105. Engleman H.M., Martin S.E., Deary I.J., Douglas N.J. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994, 343:572-575.
106. Engleman H.M., Martin S.E., Deary I.J., Douglas N.J. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax 1997, 52:114-119.
107. Engleman H.M., Martin S.E., Kingshott R.N., Mackay T.W., Deary I.J., Douglas N.J. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998, 53:341-345.
108. Faccenda J.F., Mackay T.W., Boon N.A., Douglas N.J. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001, 163:344-348.
109. McArdle N., Douglas N.J. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med 2001, 164:1459-1463.
110. Ballester E., Badia J.R., Hernandez L., Carrasco E., de Pablo J., Fornas C., et al. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999, 159:495-501.
111. Barbe F., Mayoralas L.R., Duran J., Masa J.F., Maimo A., Montserrat J.M., et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness a randomized controlled trial. Ann Intern Med 2001, 134:1015-1023.
112. Becker H.F., Jerrentrup A., Ploch T., Grote L., Penzel T., Sullivan C.E., et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003, 107:68-73.
113. Chong M, Ayalon L, Marler M, Loredo J, Corey-Bloom J, Palmer B, et al. Continuous positive airway pressure reduces subjective daytime sleepiness in mild-moderate Alzheimer's disease patients with sleep disordered breathing. Journal of Geriatric Society of America (in press).
114. Hack M., Davies R.J., Mullins R., Choi S.J., Ramdassingh-Dow S., Jenkinson C., et al. Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnoea. Thorax 2000, 55:224-231.
115. Henke K.G., Grady J.J., Kuna S.T. Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apnea-hypopnea syndrome A randomized placebo-controlled trial. Am J Respir Crit Care Med 2001, 163:911-917.
116. Jenkinson C., Davies R.J.O., Mullins R., Stradling J.R. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999, 353:2100-2105.
117. Montserrat J.M., Ferrer M., Hernandez L., Farre R., Vilagut G., Navajas D., et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. Am J Respir Crit Care Med 2001, 164:608-613.
118. Nelesen R.A., Yu H., Ziegler M.G., Mills P.J., Clausen J.L., Dimsdale J.E. Continuous positive airway pressure normalizes cardiac autonomic and hemodynamic responses to a laboratory stressor in apneic patients. Chest 2001, 119:1092-1101.
119. Pepperell J.C., Ramdassingh-Dow S., Crosthwaite N., Mullins R., Jenkinson C., Stradling J.R., et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002, 359:204-210.
120. Profant J., Ancoli-Israel S., Dimsdale J.E. A randomized controlled trial of 1 week of continuous positive airway pressure treatment on quality of life. Heart Lung 2003, 32:52-58.
121. Redline S., Adams N., Strauss M.E., Roebuck T., Winters M., Rosenberg C. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med 1998, 157:858-865.
122. Zhang X., Yin K., Wang H., Su M., Yang Y. Effect of continuous positive airway pressure treatment on elderly Chinese patients with obstructive sleep apnea in the prethrombotic state. Chin Med J (Engl) 2003, 116:1426-1428.
123. Ziegler M.G., Mills P.J., Loredo J.S., Ancoli-Israel S., Dimsdale J.E. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 2001, 120:887-893.
124. Kajaste S., Brander P.E., Telakivi T., Partinen M., Mustajoki P. A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med 2004, 5:125-131.
125. Monasterio C., Vidal S., Duran J., Ferrer M., Carmona C., Barbe F., et al. Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001, 164:939-943.
126. Robinson G.V., Pepperell J.C., Segal H.C., Davies R.J., Stradling J.R. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 2004, 5:777-782.
127. Robinson G.V., Smith D.M., Langford B.A., Davies R.J., Stradling J.R. CPAP does not reduce blood pressure in non-sleepy hypertensive OSA patients. Eur Respir J 2006, 27:234-238.
128. Engleman H.M., Kingshott R.N., Wraith P.K., Mackay T.W., Deary I.J., Douglas N.J. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med 1999, 159:461-467.
129. Kohler M., Pepperell J.C., Casadei B., Craig S., Crosthwaite N., Stradling J.R., et al. CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 2008, 32:1488-1496.
130. Ruttanaumpawan P., Gilman M.P., Usui K., Floras J.S., Bradley T.D. Sustained effect of continuous positive airway pressure on baroreflex sensitivity in congestive heart failure patients with obstructive sleep apnea. J Hypertens 2008, 26:1163-1168.
131. Noda A., Nakata S., Koike Y., Miyata S., Kitaichi K., Nishizawa T., et al. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res 2007, 30:669-676.
132. Lim W., Bardwell W.A., Loredo J.S., Kim E.J., Ancoli-Israel S., Morgan E.E., et al. Neuropsychological effects of 2-week continuous positive airway pressure treatment and supplemental oxygen in patients with obstructive sleep apnea: a randomized placebo-controlled study. J Clin Sleep Med 2007, 3:380-386.
133. West S.D., Nicoll D.J., Wallace T.M., Matthews D.R., Stradling J.R. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007, 62:969-974.
134. Haensel A., Norman D., Natarajan L., Bardwell W.A., Ancoli-Israel S., Dimsdale J.E. Effect of a 2 week CPAP treatment on mood states in patients with obstructive sleep apnea: a double-blind trial. Sleep Breath 2007, 11:239-244.
135. Campos-Rodriguez F., Grilo-Reina A., Perez-Ronchel J., Merino-Sanchez M., Gonzalez-Benitez M.A., Beltran-Robles M., et al. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 2006, 129:1459-1467.
136. To K.W., Chan W.C., Choo K.L., Lam W.K., Wong K.K., Hui D.S. A randomized cross-over study of auto-continuous positive airway pressure versus fixed-continuous positive airway pressure in patients with obstructive sleep apnoea. Respirology 2008, 13:79-86.
137. Barbe F., Duran-Cantolla J., Capote F., de la Peña M., Chiner E., Masa J.F., et al. Long-Term Effect of Continuous Positive Airway Pressure in Hypertensive Patients With Sleep Apnea. Am J Respir Crit Care Med 2010, 181:18-26.
138. Durán-Cantolla J, Aizpuru F, Martínez-Null C, Rubio R, Terán J, Alonso M, et al. Efficacy of continuous positive airway pressure (CPAP) on Patients with recently diagnosed of systemic hipertensión (SH) and obstructive sleep apnea-hypopnea (OSAH). American Thoracic Society Internation Conference 2008; 177: A805 May 16-21 Toronto, Ontario, Canada.
139. Parra O., Sánchez-Armengol M.A., Bonnin M., Arboix A., Gil Peralta A., Campos F., et al. Utilidad del tratamiento con CPAP nasal en pacientes con primer episodio de ictus y síndrome de apneas obstructivas del sueño (SAOS). Estudio multicéntrico (PII de sueño). Resultados preliminares. Arch Bronconeumol 2008, 44 (Espec. Congr.):206.
140. Ancoli-Israel S., Palmer B.W., Cooke J.R., Corey-Bloom J., Florentino L., Natarajan L., et al. Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: A randomized controlled study. J Am Geriatr Soc 2008, 56:2076-2081.
141. Aloia M.S., Ilniczky N., Di Dio P. Neuropsychological changes and treatment compliance in older adults with sleep apnea. J Psychosom Res 2003, 56:549-553.
142. Lewis K.E., Seale L., Bartle I.E., Watkins A.J., Veden P. Early predictors of CPAP use for the treatment of obstructive sleep apnea. Sleep 2004, 27:134-138.
143. Kotsikas K., Browne H.A.K., Ghiassi R., Adams L., Simonds A.K., Morrell M.J. The determinants of therapeutic levels of continuous positive airway pressure in elderly sleep apnea patients. Respir Med 2006, 100:1216-1225.